peoplePerson
Uwe Haberkorn
Nuclear medicine physician whose group invented FAPI PET tracers and pioneered PSMA and FAP radioligand therapy.
Uwe Haberkorn's Heidelberg group developed the quinoline-based FAP inhibitor (FAPI) tracers that image most epithelial cancers and led early PSMA-617 and FAP-targeted therapy in humans.
Role
Head of Nuclear Medicine, Heidelberg University Hospital and DKFZ
Institution
Specialisms
Nuclear medicineFAP-targeted radiopharmaceuticalsTheranostics
Profiles
| Title | Journal | Year |
|---|---|---|
| 68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer | Journal of Nuclear Medicine | 2019 |